These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21997889)

  • 21. Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells.
    Clever YP; Cremers B; Krauss B; Böhm M; Speck U; Laufs U; Scheller B
    EuroIntervention; 2011 May; 7 Suppl K():K32-42. PubMed ID: 22027725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model.
    Tada N; Virmani R; Grant G; Bartlett L; Black A; Clavijo C; Christians U; Betts R; Savage D; Su SH; Shulze J; Kar S
    Circ Cardiovasc Interv; 2010 Apr; 3(2):174-83. PubMed ID: 20407114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local perivascular delivery of anti-restenotic agents from a drug-eluting poly(epsilon-caprolactone) stent cuff.
    Pires NM; van der Hoeven BL; de Vries MR; Havekes LM; van Vlijmen BJ; Hennink WE; Quax PH; Jukema JW
    Biomaterials; 2005 Sep; 26(26):5386-94. PubMed ID: 15814137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental study of Mytrolimus-eluting stents on preventing restenosis in porcine coronary model].
    Qiu H; Gao RL; Tang ZR; Meng L; Zhao H; Ruan YM; Zhao H; Yang YJ; Chen JL; Chen ZJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jun; 33(6):561-4. PubMed ID: 16053797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent.
    Udipi K; Chen M; Cheng P; Jiang K; Judd D; Caceres A; Melder RJ; Wilcox JN
    J Biomed Mater Res A; 2008 Jun; 85(4):1064-71. PubMed ID: 17937416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling of degradation and drug release from a biodegradable stent coating.
    Prabhu S; Hossainy S
    J Biomed Mater Res A; 2007 Mar; 80(3):732-41. PubMed ID: 17167794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo changes to PLGA/sirolimus coating on drug eluting stents.
    Xi T; Gao R; Xu B; Chen L; Luo T; Liu J; Wei Y; Zhong S
    Biomaterials; 2010 Jul; 31(19):5151-8. PubMed ID: 20382420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
    Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
    J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The release kinetics of drug eluting stents containing sirolimus as coated drug: role of release media.
    Naseerali CP; Hari PR; Sreenivasan K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(7-8):709-12. PubMed ID: 20138593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a vessel-simulating flow-through cell method for the in vitro evaluation of release and distribution from drug-eluting stents.
    Neubert A; Sternberg K; Nagel S; Harder C; Schmitz KP; Kroemer HK; Weitschies W
    J Control Release; 2008 Aug; 130(1):2-8. PubMed ID: 18562035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
    Ray GM; Nawarskas JJ; Frishman WH
    Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial cell recovery between comparator polymer-based drug-eluting stents.
    Joner M; Nakazawa G; Finn AV; Quee SC; Coleman L; Acampado E; Wilson PS; Skorija K; Cheng Q; Xu X; Gold HK; Kolodgie FD; Virmani R
    J Am Coll Cardiol; 2008 Jul; 52(5):333-42. PubMed ID: 18652940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanistic analysis of drug release from tablets with membrane controlled drug delivery.
    Strübing S; Metz H; Mäder K
    Eur J Pharm Biopharm; 2007 Apr; 66(1):113-9. PubMed ID: 17101269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
    Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent.
    Beijk MA; Piek JJ
    Expert Rev Med Devices; 2007 Jan; 4(1):11-21. PubMed ID: 17187467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug loading and elution from a phosphorylcholine polymer-coated coronary stent does not affect long-term stability of the coating in vivo.
    Lewis AL; Willis SL; Small SA; Hunt SR; O'byrne V; Stratford PW
    Biomed Mater Eng; 2004; 14(4):355-70. PubMed ID: 15472385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of drug coating on drug eluting stents].
    Luo LL; Wang GX; Yin TY
    Zhongguo Yi Liao Qi Xie Za Zhi; 2006 Mar; 30(2):117-9. PubMed ID: 16830805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.